BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37967775)

  • 1. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice.
    Zheng N; Wang H; Zhu W; Li Y; Li H
    J Ethnopharmacol; 2024 Feb; 320():117401. PubMed ID: 37967775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
    Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism.
    Lu Y; Shao M; Zhang C; Xiang H; Wang J; Wu T; Ji G
    Front Pharmacol; 2022; 13():946360. PubMed ID: 36249786
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
    Wang S; Sheng F; Zou L; Xiao J; Li P
    J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway.
    Xin Y; Li X; Zhu X; Lin X; Luo M; Xiao Y; Ruan Y; Guo H
    J Nutr; 2023 Jul; 153(7):1903-1914. PubMed ID: 37269906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats.
    Tang Y; Zhang J; Li J; Lei X; Xu D; Wang Y; Li C; Li X; Mao Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1293-1304. PubMed ID: 31170503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
    Huang S; Wu Q; Liu H; Ling H; He Y; Wang C; Wang Z; Lu Y; Lu Y
    J Ethnopharmacol; 2019 Sep; 241():111976. PubMed ID: 31132462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry.
    An JP; Choi JH; Huh J; Lee HJ; Han S; Noh JR; Kim YH; Lee CH; Oh WK
    Phytomedicine; 2019 Oct; 63():152999. PubMed ID: 31280138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
    Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
    Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smilax China L. polysaccharide prevents HFD induced-NAFLD by regulating hepatic fat metabolism and gut microbiota.
    Zhang W; Yu L; Yang Q; Zhang J; Wang W; Hu X; Li J; Zheng G
    Phytomedicine; 2024 May; 127():155478. PubMed ID: 38452696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of bile acid composition in high fat diet-induced nonalcoholic fatty liver disease in obese diabetic rats.
    Nakade Y; Kitano R; Sakamoto K; Kimoto S; Yamauchi T; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
    PLoS One; 2021; 16(2):e0247303. PubMed ID: 33626072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.